微导管栓塞:微粒 微导管栓塞:Onyx 胶 内脏动脉瘤 内瘘 微导管应用:血管塞
返回首页

微导管应用:栓塞微粒(2)

时间:2020-04-02 20:26来源:未知 作者:Mr.Editor
Hand-cut Pumping Dr. Miyuki Sone GS Is Biodegradable 一般在1-3周内吸收..Typically absorbed in 1-3 weeks. 慢性炎症可导致血管狭窄或阻塞 Vessel stenosis or occlusion can occur due to chronic inflammatio


Hand-cut
Pumping
Dr. Miyuki Sone 



GS Is Biodegradable
 一般在1-3周内吸收..Typically absorbed in 1-3 weeks.
慢性炎症可导致血管狭窄或阻塞 Vessel stenosis or occlusion can occur due to chronic inflammation 
Nippon Kayaku Co. Ltd


 Calibrated microspheres

        Bland
        Drug-eluting

  • 对常规栓塞微粒缺点的对应,90年代发展起来的栓塞微粒 Developed since 1990’s in response to drawbacks of conventional particles
  • 表面光滑的惰性合成聚合物 Inert synthetic polymer with a smooth surface
  • 栓塞微粒的粒径均匀一致 Homogenous particle size
  • 可压缩 - 轻松通过微导管 Compressible --- easy microcatheter passage
  • 药物荷载 Drug-loadable
 
Homogeneous size
Compressed spheres in a microcatheter

Color Coding For Various Size Ranges


Bland-beads (40-1200μm)
Embosphere
BeadBlock
Embozene


Color Coding For Various Size Ranges


Drug-eluting beads(30-700μm)
HepaSphere
DC-Bead
Tandem


Microsphere: How to Occlude a Vessel?

  • 与PVA/GS比较,微粒可以在血管内行进到更末梢的血管 Microspheres travel far distally compared with PVA/GS
  • 一个微粒可以阻塞蒸锅血管腔 A single particle occupies entirely a vessel lumen
  • 阻塞水平和微粒的粒径相关 Occlusion level is well correlated with particle size.
             可以预期和控制阻塞的水平 Prediction and control of occlusion level
             靶向栓塞减少正常组织的损伤 Targeted embolization to minimize normal tissue damage

mbosphere 100-300 μm
 
 
Deep Penetration of Microspheres:Case: Nasal angiofibroma
顶一下
(1)
100%
踩一下
(0)
0%
------分隔线----------------------------
  • 上一篇:没有了
  • 下一篇:没有了
推荐内容